Literature DB >> 27367324

Changing modalities of outpatient parenteral antimicrobial therapy use over time in Italy: a comparison of two time periods.

Silvano Esposito1, Silvana Noviello1, Giovanni Boccia2, Giuseppe De Simone1, Pasquale Pagliano3, Francesco De Caro2.   

Abstract

This study aimed to assess the extent and nature of recent changes in the management of outpatient parenteral antimicrobial therapy (OPAT) in Italy. We reviewed our previously reported data from 1999 to 2003 and compared them with data from patients who received OPAT from 2005 to 2010. Data for 1175 patients who received OPAT were analysed. Skin and soft tissue infections (SSTIs) were the most common infection treated with OPAT in both time periods, but an increase in patients with SSTIs receiving OPAT was observed. By contrast, a decline over time of OPAT use was found for patients affected by pneumonia. Furthermore, ceftriaxone use declined, whereas teicoplanin increased over time. In conclusion, OPAT use has significantly changed over time in Italy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27367324

Source DB:  PubMed          Journal:  Infez Med        ISSN: 1124-9390


  4 in total

1.  Attitudes of physicians from 10 European countries on adherence and how treatment modalities in ABSSSI affect adherence: results from a Delphi survey.

Authors:  Tom Stargardt; Christian Eckmann; Emilio Bouza; Gian Maria Rossolini; Paolo Antonio Grossi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-06-06       Impact factor: 3.267

2.  Clinical outcomes of teicoplanin use in the OPAT setting.

Authors:  Hannah Dabrowski; Helena Wickham; Surjo De; Jonathan Underwood; Stephen Morris-Jones; Sarah Logan; Michael Marks; Gabriele Pollara
Journal:  Int J Antimicrob Agents       Date:  2020-01-08       Impact factor: 5.283

3.  Consumption of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in the community, European Union/European Economic Area, 1997-2017.

Authors:  Ann Versporten; Robin Bruyndonckx; Niels Adriaenssens; Niel Hens; Dominique L Monnet; Geert Molenberghs; Herman Goossens; Klaus Weist; Samuel Coenen
Journal:  J Antimicrob Chemother       Date:  2021-07-26       Impact factor: 5.790

4.  Consumption of cephalosporins in the community, European Union/European Economic Area, 1997-2017.

Authors:  Ann Versporten; Robin Bruyndonckx; Niels Adriaenssens; Niel Hens; Dominique L Monnet; Geert Molenberghs; Herman Goossens; Klaus Weist; Samuel Coenen
Journal:  J Antimicrob Chemother       Date:  2021-07-26       Impact factor: 5.790

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.